Optimizing glycemic control in type 2 diabetes: the impact of the GLIDE program’s personalized digital health intervention
2024

Improving Blood Sugar Control in Type 2 Diabetes with the GLIDE Program

Sample size: 30 publication 10 minutes Evidence: moderate

Author Information

Author(s): Ambesange Anand, Khomane Amit Lala, Parikh Jaymin, Aswal Devina, Gharia Mihir, Sharma Prachi, Trivedi Vishva, Maheshwari Twinkle, Mishra Astha, Bhavsar Bhavan, Athavale Vrushali

Primary Institution: Digicare Health Solutions Private Limited

Hypothesis

The GLIDE program's personalized digital health intervention will improve glycemic control in type 2 diabetes patients over 90 days.

Conclusion

The GLIDE program significantly improved glycemic control in type 2 diabetes patients through personalized interventions.

Supporting Evidence

  • 27 out of 30 patients adhered to the GLIDE program.
  • HbA1c levels decreased by 11.79% after the intervention.
  • Significant reductions in fasting and postprandial blood sugar levels were observed.
  • Patients logged into the app an average of 4.3 times per day.
  • High patient engagement correlated with greater reductions in HbA1c levels.
  • Customer Satisfaction Score (CSAT) was 93% among participants.
  • Participants showed a mean weight reduction of 2.84 kg after the program.
  • Regular follow-ups ensured continuous progress tracking and plan adjustments.

Takeaway

The GLIDE program helps people with diabetes manage their blood sugar better by giving them personalized diet and exercise plans.

Methodology

The study involved a 90-day intervention with 30 type 2 diabetes patients using personalized diet and exercise plans, monitored through IoT devices.

Potential Biases

The requirement for smartphone access and English literacy may introduce selection bias.

Limitations

The study had a small sample size and lacked a control group, which limits the generalizability of the findings.

Participant Demographics

The cohort included 56% females, with a mean age of 57 years, all residing in metropolitan areas.

Statistical Information

P-Value

<0.05

Confidence Interval

95% CI, 0.63–0.92

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fcdhc.2024.1494009

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication